Kaneh Bosm BioTechnology Inc. (CNSX:KBB) entered into an agreement to acquire Farmakem Ltd. for CAD 10.6 million on July 12, 2018. Pursuant to the terms of agreement, Kaneh Bosm will pay CAD 0.99 million in cash and will issue 19.13 million shares. The consideration is payable over the course of several milestones. Kaneh Bosm BioTechnology Inc. (CNSX:KBB) cancelled the acquisition of Farmakem Ltd. on July 12, 2019.